These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 9258601)

  • 1. Antisense regulation of oncogenes in human cancer.
    Mukhopadhyay T; Roth JA
    Crit Rev Oncog; 1996; 7(3-4):151-90. PubMed ID: 9258601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antisense oligonucleotides: the state of the art.
    Aboul-Fadl T
    Curr Med Chem; 2005; 12(19):2193-214. PubMed ID: 16178780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antisense strategy: biological utility and prospects in the treatment of hematological malignancies.
    Warzocha K; Wotowiec D
    Leuk Lymphoma; 1997 Jan; 24(3-4):267-81. PubMed ID: 9156656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antisense approaches to cancer gene therapy.
    Mercola D; Cohen JS
    Cancer Gene Ther; 1995 Mar; 2(1):47-59. PubMed ID: 7621254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antisense oligonucleotides for cancer therapy-an overview.
    Stahel RA; Zangemeister-Wittke U
    Lung Cancer; 2003 Aug; 41 Suppl 1():S81-8. PubMed ID: 12867066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer gene suppression strategies: issues and potential.
    Passioura T; Symonds G
    Curr Issues Mol Biol; 2004 Jul; 6(2):89-101. PubMed ID: 15119820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antisense of oligonucleotides and the inhibition of oncogene expression.
    Prins J; de Vries EG; Mulder NH
    Clin Oncol (R Coll Radiol); 1993; 5(4):245-52. PubMed ID: 8398922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antisense oligonucleotides as therapeutics for malignant diseases.
    Ho PT; Parkinson DR
    Semin Oncol; 1997 Apr; 24(2):187-202. PubMed ID: 9129689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applications of antisense oligonucleotides in oncology.
    Pierga JY; Magdelenat H
    Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):237-61. PubMed ID: 7920172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antisense comes of age.
    Flanagan WM
    Cancer Metastasis Rev; 1998 Jun; 17(2):169-76. PubMed ID: 9770113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleic acid modulation of gene expression: approaches for nucleic acid therapeutics against cancer.
    Nakata Y; Kim TK; Shetzline S; Gewirtz AM
    Crit Rev Eukaryot Gene Expr; 2005; 15(2):163-82. PubMed ID: 16022634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer therapy via modulation of micro RNA levels: a promising future.
    Kota SK; Balasubramanian S
    Drug Discov Today; 2010 Sep; 15(17-18):733-40. PubMed ID: 20692360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antisense therapy.
    Narayanan R; Akhtar S
    Curr Opin Oncol; 1996 Nov; 8(6):509-15. PubMed ID: 8971471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of apoptosis in small-cell lung cancer cells by an antisense oligodeoxynucleotide targeting the Bcl-2 coding sequence.
    Ziegler A; Luedke GH; Fabbro D; Altmann KH; Stahel RA; Zangemeister-Wittke U
    J Natl Cancer Inst; 1997 Jul; 89(14):1027-36. PubMed ID: 9230884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antisense therapy for cancer.
    Gleave ME; Monia BP
    Nat Rev Cancer; 2005 Jun; 5(6):468-79. PubMed ID: 15905854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antisense oligonucleotides: target validation and development of systemically delivered therapeutic nanoparticles.
    Zhang C; Pei J; Kumar D; Sakabe I; Boudreau HE; Gokhale PC; Kasid UN
    Methods Mol Biol; 2007; 361():163-85. PubMed ID: 17172711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical and clinical experience of antisense therapy for solid tumors.
    Webb MS; Zon G
    Curr Opin Mol Ther; 1999 Aug; 1(4):458-63. PubMed ID: 11713760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combinatorial application of nucleic acid-based agents targeting protein kinases for cancer treatment.
    Spänkuch B; Strebhardt K
    Curr Pharm Des; 2008; 14(11):1098-112. PubMed ID: 18473857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of alternative splicing by antisense oligonucleotides as a potential chemotherapy: effects on gene expression.
    Mercatante DR; Kole R
    Biochim Biophys Acta; 2002 Jul; 1587(2-3):126-32. PubMed ID: 12084454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of protooncogene expression by antisense oligodeoxynucleotides: biological and therapeutic implications.
    Calabretta B
    Cancer Res; 1991 Sep; 51(17):4505-10. PubMed ID: 1873794
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.